Pulmatrix :
PULM
PULM
Stock Data
$1.32
$0.03 (2.33%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Pulmatrix, Inc., a clinical-stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company is headquartered in Lexington, Massachusetts.
All Pulmatrix Articles
1 Article
No articles found for Pulmatrix.